Advertisement
Screener

Deciphera Pharmaceuticals, Inc. Form DEFA14A: Additional definitive proxy soliciting materials

Deciphera Pharmaceuticals, Inc. Form DEFA14A: Additional definitive proxy soliciting materials

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2024-04-25: Form DEFA14A; Description DEFA14A; Document dcphproxyadditionalmateria.htm.
  • 2023-04-26: Form DEFA14A; Description DEFA14A; Document dcphproxyadditionalmateria.htm.
  • 2022-04-26: Form DEFA14A; Description DEFA14A; Document dcphproxyadditionalmateria.htm.
  • 2021-04-29: Form DEFA14A; Description DEFA14A; Document dcphproxyadditionalmateria.htm.
FiledFormPeriod of reportDescriptionDocument
2024-04-25DEFA14ADEFA14Adcphproxyadditionalmateria.htm
2023-04-26DEFA14ADEFA14Adcphproxyadditionalmateria.htm
2022-04-26DEFA14ADEFA14Adcphproxyadditionalmateria.htm
2021-04-29DEFA14ADEFA14Adcphproxyadditionalmateria.htm
2020-04-24DEFA14ADEFA14Ad795887ddefa14a.htm
2019-04-22DEFA14ADEFA14Ad686231ddefa14a.htm
2018-04-03DEFA14ADEFA14Ad518842ddefa14a.htm